Two new criteria of the metabolic syndrome: Prevalence and the association with brachial-ankle pulse wave velocity in Japanese male workers

Journal of Occupational Health

Volumn 48, Issue 2, 2006, Pages 134-140

  Miyaki, Koichi ^a,b   Hara, Asako ^a   Naito, Mariko ^c   Naito, Toru ^d   Nakayama, Takeo ^e  

^a KEIO UNIVERSITY   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^c NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d FUKUOKA DENTAL COLLEGE   (Japan)

^e KYOTO UNIVERSITY SCHOOL OF PUBLIC HEALTH   (Japan)

Author keywords

baPWV; Japan; Metabolic syndrome; New criteria

Indexed keywords

ADULT; ARTICLE; BLOOD SAMPLING; CHEMICAL INDUSTRY; CLINICAL FEATURE; CONTROLLED STUDY; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PHYSICAL EXAMINATION; PREVALENCE; PULSE WAVE; QUESTIONNAIRE; WAIST CIRCUMFERENCE;

ADULT; BLOOD FLOW VELOCITY; BRACHIAL ARTERY; CROSS-SECTIONAL STUDIES; HUMANS; JAPAN; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OCCUPATIONAL EXPOSURE; PULSE;

EID: 33646465436     PISSN: 13419145     EISSN: 13419145     Source Type: Journal    
DOI: 10.1539/joh.48.134     Document Type: Article

References (40)

1. GM Reaven: Banting lecture 1988: role of insulin resistance in human disease. Diabetes 37, 1595-1607 (1988)
2. NM Kaplan: The deadly quartet: upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension. Arch Intern Med 149, 1514-1520 (1989)
3. MI Schmidt, RL Watson, BB Duncan, P Metcalf, FL Brancati, AR Sharrett, CE Davis and G Heiss: Clustering of dyslipidemia, hyperuricemia, diabetes, and hypertension and its association with fasting insulin and central and overall obesity in a general population. Metabolism 45, 699-706 (1996)
4. PWF Wilson, WB Kannel, H Silbershatz and RB D'Agostino: Clustering of metabolic factors and coronary heart disease. Arch Intern Med 159, 1104-1109 (1999)
5. N Nakanishi, K Suzuki and K Tatara: Clustered features of the metabolic syndrome and the risk for increased aortic pulse wave velocity in middle-aged Japanese men. Angiology 54, 551-559 (2003)
6. C Lorenzo, M Okoloise, K Williams, MP Stern and SM Haffner: San Antonio Heart Study. The metabolic syndrome as predictor of type 2 diabetes: the San Antonio heart study. Diabetes Care 26, 3153-3159 (2003)
7. N Nakanishi, T Takatorige, H Fukuda, K Shirai, W Li, M Okamoto, H Yoshida, Y Matsuo, K Suzuki and K Tatara: Components of the metabolic syndrome as predictors of cardiovascular disease and type 2 diabetes in middle-aged Japanese men. Diabetes Res Clin Pract 64, 59-70 (2004)
8. B Isomaa, P Almgren, T Tuomi, B Forsen, K Lahti, M Nissen, MR Taskinen and L Groop: Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 24, 683-689 (2001)
9. HM Lakka, DE Laaksonen, TA Lakka, LK Niskanen, E Kumpusalo, J Tuomilehto and JT Salonen: The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 288, 2709-2716 (2002)
10. S Malik, ND Wong, SS Franklin, TV Kamath, GJ L'Italien, JR Pio and GR Williams: Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation 110, 1245-1250 (2004)
11. AM McNeill, WD Rosamond, CJ Girman, G Heiss, SH Golden, BB Duncan, HE East and C Ballantyne: Prevalence of coronary heart disease and carotid arterial thickening in patients with the metabolic syndrome (The ARIC Study). Am J Cardiol 94, 1249-1254 (2004)
12. AM McNeill, WD Rosamond, CJ Girman, SH Golden, MI Schmidt, HE East, CM Ballantyne and G Heiss: The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study. Diabetes Care 28, 385-390 (2005)
13. KG Alberti and PZ Zimmet: Definition, diagnosis and classification of diabetes melli-tus and its complications: Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15, 539-553 (1998)
14. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 285, 2486-2497 (2001)
15. YW Park, S Zhu, L Palaniappan, S Heshka, MR Carnethon and SB Heymsfield: The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med 163, 427-436 (2003)
16. CE Tan, S Ma, D Wai, SK Chew and ES Tai: Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians? Diabetes Care 27, 1182-1186 (2004)
17. WY Lee, JS Park, SY Noh, EJ Rhee, SW Kim and PZ Zimmet: Prevalence of the metabolic syndrome among 40,698 Korean metropolitan subjects. Diabetes Res Clin Pract 65, 143-149 (2004)
18. ES Kim, SM Han, YI Kim, KH Song, MS Kim, WB Kim, JY Park and KU Lee: Prevalence and clinical characteristics of metabolic syndrome in a rural population of South Korea. Diabet Med 21, 1141-1143 (2004)
19. ME Jorgensen, P Bjerregaard, F Gyntelberg and K Borch-Johnsen: Greenland population study: prevalence of the metabolic syndrome among the Inuit in Greenland. A comparison between two proposed definitions. Diabet Med 21, 1237-1242 (2004)
20. R Gupta, PC Deedwania, A Gupta, S Rastogi, RB Panwar and K Kothari: Prevalence of metabolic syndrome in an Indian urban population. Int J Cardiol 97, 257-261 (2004)
21. B Enkhmaa, K Shiwaku, E Anuurad, A Nogi, K Kitajima, M Yamasaki, T Oyunsuren and Y Yamane: Prevalence of the metabolic syndrome using the Third Report of the National Cholesterol Educational Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (ATP III) and the modified ATP III definitions for Japanese and Mongolians. Clin Chim Acta 352, 105-113 (2005)
22. GN Thomas, SY Ho, ED Janus, KS Lam, AJ Hedley and TH Lam: Hong Kong Cardiovascular Risk Factor Prevalence Study Steering Committee: The US National Cholesterol Education Programme Adult Treatment Panel III (NCEP ATP III) prevalence of the metabolic syndrome in a Chinese population. Diabetes Res Clin Pract 67, 251-257 (2005)
23. T Tillin, N Forouhi, DG Johnston, PM McKeigue, N Chaturvedi and IF Godsland: Metabolic syndrome and coronary heart disease in South Asians, African-Caribbeans and white Europeans: a UK population-based cross-sectional study. Diabetologia 48, 649-656 (2005)
24. International Diabetes Federation (IDF): The IDF consensus worldwide definition of the metabolic syndrome [article online]. Available from http://www.idf.org/home.
25. Definition and diagnosis criteria of metabolic syndrome. Nippon Naika Gakkai Zasshi 94, 794-809 (2005) (in Japanese)
26. R Asmar, A Benetos, J Topouchian, P Laurent, B Pannier, AM Brisac, R Target, and BI Levy: Assessment of arterial distensibility by automatic pulse wave velocity measurement: validation and clinical application studies. Hypertension 26, 485-490 (1995)
27. ED Lehmann: Clinical value of aortic pulse-wave velocity measurement. Lancet 354, 528-529 (1999)
28. U Nakamura, M Iwase, S Nohara, H Kanai, K Ichikawa and M Iida: Usefulness of brachial-ankle pulse wave velocity measurement: correlation with abdominal aortic calcification. Hypertens Res 26, 163-167 (2003)
29. A Yamashina, H Tomiyama, T Arai, K Hirose, Y Koji, Y Hirayama, Y Yamamoto and S Hori: Brachial-ankle pulse wave velocity as a marker of atherosclerotic vascular damage and cardiovascular risk. Hypertens Res 26, 615-622 (2003)
30. M Sawabe, R Takahashi, S Matsushita, T Ozawa, T Arai, A Hamamatsu, K Nakahara, K Chida, H Yamanouchi, S Murayama and N Tanaka: Aortic pulse wave velocity and the degree of atherosclerosis in the elderly: a pathological study based on 304 autopsy cases. Atherosclerosis 179, 345-351 (2005)
31. HE Lim, CG Park, SH Shin, JC Ahn, HS Seo and DJ Oh: Aortic pulse wave velocity as an independent marker of coronary artery disease. Blood Press 13, 369-375 (2004)
32. J Blacher, AP Guerin, B Pannier, SJ Marchais, ME S afar and GM London: Impact of aortic stiffness on survival in end-stage renal disease. Circulation 99, 2434-1439 (1999)
33. S Laurent, P Boutouyrie, R Asmar, I Gautier, B Laloux, L Guize, P Ducimetiere and A Benetos: Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 37, 1236-1241 (2001)
34. T Shokawa, M Imazu, H Yamamoto, M Toyofuku, N Tasaki, T Okimoto, K Yamane and N Kohno: Pulse wave velocity predicts cardiovascular mortality: findings from the Hawaii-Los Angeles-Hiroshima study. Circ J 69, 259-264 (2005)
35. A Yamashina, H Tomiyama, K Takeda, H Tsuda, T Arai, K Hirose, Y Koji, S Hori and Y Yamamoto: Validity, reproducibility, and clinical significance of noninvasive brachial-ankle pulse wave velocity measurement. Hypertens Res 25, 359-364 (2002)
36. R Imanishi, S Seto, G Toda, M Yoshida, A Ohtsuru, Y Koide, T Baba and K Yano: High brachial-ankle pulse wave velocity is an independent predictor of the presence of coronary artery disease in men. Hypertens Res 27, 71-78 (2004)
37. S Sakuragi, J Iwasaki, N Tokunaga, S Hiramatsu and T Ohe: Aortic stiffness is an independent predictor of left ventricular function in patients with coronary heart disease. Cardiology 103, 107-112 (2005)
38. J Amar, JB Ruidavets, B Chamontin, L Drouet and J Ferrieres: Arterial stiffness and cardiovascular risk factors in a population-based study. J Hypertens 19, 381-387 (2001)
39. KM Choi, KW Lee, JA Seo, JH Oh, SG Kim, NH Kim, DS Choi and SH Baik: Relationship between brachial-ankle pulse wave velocity and cardiovascular risk factors of the metabolic syndrome. Diabetes Res Clin Pract 66, 57-61 (2004)
40. ES Ford, WH Giles and WH Dietz: Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 287, 356-359 (2002)